Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

  • This share is currently suspended. It was suspended at a price of 2.45
  • There is currently no data for AGFX

Statement regarding Argentex Group

30 May 2025 09:44

RNS Number : 7919K
Lumon Acquisitions Limited
30 May 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

FOR IMMEDIATE RELEASE.

30 May 2025

No intention to make an offer for Argentex Group plc ("Argentex")

Further to the separate announcements by Argentex and Lumon Acquisitions Limited ("Lumon") on 23 Arpil 2025, Lumon announces that it does not intend to make an offer for Argentex under Rule 2.7 of the City Code on Takeovers and Mergers (the "Code").

This is a statement made in accordance with Rule 2.6(d) of the Code and to which Rule 2.8 of the Code applies. As a result of this announcement, Lumon will, together with any party acting in concert with it, be bound by the restrictions contained in Rule 2.8 of the Code.

For the purpose of Rule 2.8 of the Code, Lumon, and any person(s) acting in concert with it, reserves the right to make or participate in an offer for Argentex (and/or take any other action which would otherwise be restricted under Rule 2.8 of the Code) within six months of the date of this announcement:

a) with the agreement of the board of directors of Argentex provided that such agreement is only given if the recommended cash acquisition of Argentex by IFX (UK) Ltd is withdrawn or lapses, and only after such lapse or withdrawal;

b) following the announcement of a firm intention to make an offer for Argentex by or on behalf of a third party other than IFX;

c) if Argentex announces a Rule 9 waiver proposal (as described in Note 1 on Dispensations from Rule 9 of the Code) or a reverse takeover (as defined in the Code); 

d) if there has been a material change of circumstances (as determined by the Panel on Takeovers and Mergers (the "Panel")); or 

e) in such other circumstances as the Panel may permit.

Enquiries:

 

Lumon and Pollen Street Capital

 

c/o FGS Global

 

Cavendish Capital Markets (Financial Adviser to Lumon and Pollen Street Capital) Marc MilmoHenrik PerssonFergus Sullivan

George Lawson

+44 (0) 20 7220 0500

FGS Global (Communications adviser to Lumon)Chris Sibbald

+44 (0) 7855 955 531

 

Important information

This announcement is not intended to, and does not constitute, an offer to sell or the solicitation of an offer to subscribe for or buy, or an invitation to subscribe for or to purchase any securities, or the solicitation of any vote, in any jurisdiction. This is an announcement under Rule 2.8 of the Code and does not constitute an announcement of a firm intention to make an offer under Rule 2.7 of the Code.

The release, publication or distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe such restrictions. Any failure to comply with such restrictions may constitute a violation of the securities law of any such jurisdiction.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OFDPKKBNFBKKAPN
Date   Source Headline
26th Oct 20237:00 amRNSBoard Change
13th Sep 20237:00 amRNSInterim results for the six months to 30 June 2023
19th Jul 20232:36 pmRNSTR1 Disclosure - Gresham House Asset Management
18th Jul 20237:00 amRNSNotice of Interim Results
12th Jul 202312:55 pmRNSDirector / PDMR Dealing
10th Jul 20237:00 amRNSHalf year trading update and board changes
27th Jun 202312:20 pmRNSTR1 Notification
22nd Jun 20239:46 amRNSResult of AGM
20th Apr 20235:05 pmRNSPublication of Annual Report and Notice of AGM
12th Apr 20237:00 amRNSFull results for the 9 months to 31 December 2022
30th Mar 20237:00 amRNSNotice of Results and Presentations
13th Mar 20237:00 amRNSUpdate on counterparties
28th Feb 20237:00 amRNSBoard Announcement
26th Jan 20237:00 amRNSTrading Statement
12th Dec 20227:00 amRNSTrading Statement
17th Nov 20222:08 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSGrant of Awards Under New LTIP
8th Nov 202212:55 pmRNSNew Long Term Incentive Plan
8th Nov 20227:00 amRNSInterim Results
12th Oct 20227:00 amRNSNotice of Interim Results
3rd Oct 20227:00 amRNSTrading Update
23rd Sep 20226:05 pmRNSHolding(s) in Company
16th Sep 20227:00 amRNSNetherlands Electronic Money Licence granted
9th Sep 20221:10 pmRNSHolding(s) in Company
22nd Aug 20221:59 pmRNSResult of AGM
15th Jul 20227:00 amRNSPublication of Annual Report and Notice of AGM
6th Jul 20227:00 amRNSFull year results for period ended 31 March 2022
31st May 20227:00 amRNSNotice of Results
12th Apr 20227:00 amRNSTrading Update
8th Nov 20217:00 amRNSInterim Results
1st Nov 20217:00 amRNSInterim Results Presentations
11th Oct 20217:00 amRNSTrading Statement
27th Aug 20215:21 pmRNSHolding(s) in Company
13th Aug 20212:16 pmRNSHolding(s) in Company
12th Aug 20214:09 pmRNSHolding(s) in Company
12th Aug 20213:09 pmRNSHolding(s) in Company
12th Aug 20213:08 pmRNSHolding(s) in Company
11th Aug 20211:08 pmRNSHolding(s) in Company
11th Aug 20219:41 amRNSDirector/PDMR Shareholding
4th Aug 20216:08 pmRNSResult of AGM
29th Jul 20217:00 amRNSChange to AGM Arrangements
13th Jul 202112:04 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
5th Jul 20212:22 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSFull year results for period ending 31 March 2021
22nd Jun 20217:00 amRNSNotice of Results
11th Jun 20217:00 amRNSDirectorate Change
10th May 20217:00 amRNSManagement team update
12th Apr 20218:00 amRNSExtension of audit partner's tenure & audit tender
6th Apr 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.